Innovating Works

ALTA SRLU

Desconocido
Showing 1 to 20 of 26 results
ENDONANO: Quantitative detection of bacterial endotoxin by novel nanotechnological approaches ALTA RICERCA E SVILUPPO IN BIOTECNOLOGIE SRLU participó en un H2020 H2020-MSCA-ITN-2018 ENDONANO (Quantitative detection of bacterial endotoxin by novel nanotechnological approaches) addresses a key regulatory and safety issue,...
2018-07-19 - 2023-06-30 | Financiado
HIPGEN: Placenta expanded adherent stromal cells PLX PAD as an innovative therapy for improving recovery a... ALTA RICERCA E SVILUPPO IN BIOTECNOLOGIE SRLU participó en un H2020 H2020-SC1-2016-2017 Aim of the HIPGEN project is to develop the first cell therapy to improve functional recovery following hip fracture arthroplasty. Hip fract...
2017-11-21 - 2022-09-30 | Financiado
LIVERHOPE: SIMVASTATIN AND RIFAXIMIN AS NEW THERAPY FOR PATIENTS WITH DECOMPENSATED CIRRHOSIS ALTA RICERCA E SVILUPPO IN BIOTECNOLOGIE SRLU participó en un H2020 H2020-SC1-2016-2017 Liver cirrhosis is a very common chronic disease and one of the leading causes of death in European. Moreover, cirrhosis has a marked impact...
2016-12-09 - 2023-02-28 | Financiado
PACE: A multicenter phase IIb study using HLA unmatched allogeneic placenta derived stromal cells PLX PAD... ALTA RICERCA E SVILUPPO IN BIOTECNOLOGIE SRLU participó en un H2020 H2020-SC1-2016-2017 PACE aims to transform the treatment of patients suffering from critical limb ischemia (CLI), a disease with high medical need, because of l...
2016-12-01 - 2021-12-31 | Financiado
MarPipe: Improving the flow in the pipeline of the next generation of marine biodiscovery scientists ALTA RICERCA E SVILUPPO IN BIOTECNOLOGIE SRLU participó en un H2020 H2020-MSCA-ITN-2016 MarPipe is a consortium of 11 partners (IBP-CNR, SZN, UiT, UNIABDN, GEOMAR, KULeuven, UCC, eCOAST, MEDINA, MicroDish, Italbiotec) based in 8...
2016-08-29 - 2021-04-30 | Financiado
HEP-CAR: Mechanisms underlying hepatocellular carcinoma pathogenesis and impact of co morbidities. ALTA RICERCA E SVILUPPO IN BIOTECNOLOGIE SRLU participó en un H2020 H2020-PHC-2014-2015 Hepatocellular carcinoma (HCC) is the most common liver malignancy, with an estimated 750,000 new cases and 695,000 deaths per year, rating...
2015-12-02 - 2019-12-31 | Financiado
GLYCOVAX: A training network for the rational design of the next generation of well defined glycoconjugate vac... ALTA RICERCA E SVILUPPO IN BIOTECNOLOGIE SRLU participó en un H2020 H2020-MSCA-ITN-2015 GLYCOVAX is a network for the education of promising young scientists who will learn how to rationally design a next generation of well-defi...
2015-08-11 - 2019-10-31 | Financiado
PANDORA: Probing safety of nano objects by defining immune responses of environmental organisms ALTA RICERCA E SVILUPPO IN BIOTECNOLOGIE SRLU participó en un H2020 H2020-MSCA-ITN-2015 PANDORA (Probing safety of nano-objects by defining immune responses of environmental organisms) shall assess the global impact of engineere...
2015-08-10 - 2019-12-31 | Financiado
ImmunoAgeing: An integrated approach to dissect determinants risk factors and pathways of ageing of the immune sy... ALTA RICERCA E SVILUPPO IN BIOTECNOLOGIE SRLU participó en un H2020 H2020-PHC-2014-2015 Age-related changes in the immune system, also known as ‘immunosenescence’, have a huge detrimental impact on the health of our ageing popul...
2015-04-07 - 2019-04-30 | Financiado
ABIRISK: Anti-Biopharmaceutical Immunization:Prediction and analysis of clinical relevance to minimize the ri... ALTA RICERCA E SVILUPPO IN BIOTECNOLOGIE SRLU participó en un FP6 The ABIRISK project provides an integrated approach to the study of immunization against biopharmaceuticals, bringing together a unique pane...
2012-03-01 - 2018-02-28 | Financiado
ABIRISK: Anti Biopharmaceutical Immunization Prediction and analysis of clinical relevance to minimize the ri... ALTA RICERCA E SVILUPPO IN BIOTECNOLOGIE SRLU participó en un FP7 The ABIRISK project provides an integrated approach to the study of immunization against biopharmaceuticals, bringing together a unique pane...
Financiado
Athero-Flux: Targeting novel lipid pathways for treatment of cardiovascular disease ALTA RICERCA E SVILUPPO IN BIOTECNOLOGIE SRLU participó en un FP7 Lipid lowering has significantly reduced cardiovascular disease (CVD) mortality in EU. However, the aim to abolish CVD in EU is far from ach...
Financiado
Athero-B-Cell: Targeting and exploiting B cell functions for treatment in cardiovascular disease ALTA RICERCA E SVILUPPO IN BIOTECNOLOGIE SRLU participó en un FP7 Cardiovascular disease (CVD) mortality and morbidity is predicted to increase in Europe and worldwide in the next decades due to aging and t...
Financiado
ADITEC: Advanced Immunization Technologies ALTA RICERCA E SVILUPPO IN BIOTECNOLOGIE SRLU participó en un FP7 Vaccines so far have been developed mostly by following an empiric approach. To prevent and possibly cure unresolved and emerging infectious...
Financiado
HERACLES: Human cystic Echinococcosis ReseArch in CentraL and Eastern Societies ALTA RICERCA E SVILUPPO IN BIOTECNOLOGIE SRLU participó en un FP7 Human cystic echinococcosis (CE), one of the most widespread helminthic zoonoses, is a chronic disease caused by infection with the larval s...
Financiado
PANACREAS: Integrating chemical approaches to treat pancreatic cancer making new leads for a cure ALTA RICERCA E SVILUPPO IN BIOTECNOLOGIE SRLU participó en un FP7 Pancreatic ductal adenocarcinoma (PDAC) causes 34000 deaths in the EU every year. Conventional cancer treatments have close to no impact on...
Financiado
TIMER: TargetIng novel MEchanisms of Resolution in inflammation ALTA RICERCA E SVILUPPO IN BIOTECNOLOGIE SRLU participó en un FP7 Resolution of inflammation is a key determinant of pathology, and an active process which involves diverse pathways and molecules. The gener...
Financiado
BioCog: Biomarker Development for Postoperative Cognitive Impairment in the Elderly ALTA RICERCA E SVILUPPO IN BIOTECNOLOGIE SRLU participó en un FP7 Postoperative delirium (POD) is characterized by the progressive deterioration of sensory/cognitive function after surgery with incidences o...
Financiado
STAR-T REK: Set up and comparison of multiple stem cell approaches for kidney repair ALTA RICERCA E SVILUPPO IN BIOTECNOLOGIE SRLU participó en un FP7 With the increasing rate of end-stage renal failure and limited alternatives for its treatment, potential regenerative approaches for kidney...
Financiado
PathCO: Pathogen COinfection HIV Tuberculosis Malaria and Hepatitis C virus ALTA RICERCA E SVILUPPO IN BIOTECNOLOGIE SRLU participó en un FP7 Acquired immune deficiency (AIDS), tuberculosis (TB) and malaria are the primary infectious diseases causing death world wide. In addition t...
Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.